Specialty Pharmacy

Topical medications that treat skin conditions prompt stem cells in the brain to repair damage.

Regulating PD-L1 protein that helps cancer evade immune system suggests new therapeutic approach.

Patients should be counseled that there is no safe level of alcohol consumption.

The FDA today approved a second-line treatment for metastatic colorectal cancer.

The FDA has awarded Breakthrough Therapy status to crizotinib (Xalkori) for ROS1-positive non-small cell lung cancer.

Novel pathway regulating immune cell movement may help eliminate debilitating effects of several serious diseases.

Pushing treatment with natalizumab from 4 weeks up to 8 weeks shows promising results.

Researchers determine mechanism for poor survival rates in African American patients with estrogen-receptor positive breast cancer.

Pharmacists in North Dakota came closer to attaining provider status when state Gov. Jack Dalrymple recently signed 4 laws recognizing pharmacists as providers.

Mild exercise found to improve fatigue and depression.

Medication also used in treatment of Crohn's disease effective at blocking pathways.

Mild cognitive impairment can set in prior to the start of therapy.

Phenytoin helps to reduce damage to the nerve fiber.

Itraconazole shows some promise in treatment of metastatic prostate cancer.

The FDA has granted Orphan Drug Designation to AstraZeneca's selumetinib.

Orphan drugs and breakthrough therapies last year comprised the highest number of new medications approved since 2001.

Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses how specialty pharmacists can help manage difficult lung cancer therapy.

Mortality gap in cancer deaths among African Americans and Caucasians may eventually disappear.

Treatment found to improve several measures of disease activity and quality of life in patients with Behçet's disease.

Study suggests substances in synthetic marijuana may damage human cell DNA.

Abiraterone acetate (Zytiga) significantly prolongs survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.

Researchers find biological evidence of repaired myelin.

Kick and kill strategy uses vaccine to stimulate immune system.

Abbott's new blood glucose meter is now widely available OTC without insurance co-pays.

Treatment will be available for clinical trials in patients with certain types of leukemia and non-Hodgkin lymphomas later this year.

Combination of nintedanib with docetaxel primarily depends on whether patients already had brain metastases.

UnitedHealth Group's Dr. Richard Migliori to speak at upcoming conference.

States with expanded Medicaid saw 25% more prescriptions filled last year.

Supplements containing creatine or androstenedione significantly increase disease risk.

A pharmacist who posted derogatory comments about a customer on social media is now being investigated by the National Health Service.